HOTAIRM1 and neoplasm: Based on a literature analysis, we identified MEG3 and HOTAIRM1 as inhibitors of the Wnt/β-catenin pathway in oral squamous cell carcinoma, melanoma, and hepatocellular carcinoma [31–33], suggesting a broader tumor-suppressive role.